1. Home
  2. DGLY vs SNPX Comparison

DGLY vs SNPX Comparison

Compare DGLY & SNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DGLY
  • SNPX
  • Stock Information
  • Founded
  • DGLY 2004
  • SNPX 2012
  • Country
  • DGLY United States
  • SNPX United States
  • Employees
  • DGLY N/A
  • SNPX N/A
  • Industry
  • DGLY Radio And Television Broadcasting And Communications Equipment
  • SNPX Medicinal Chemicals and Botanical Products
  • Sector
  • DGLY Technology
  • SNPX Health Care
  • Exchange
  • DGLY Nasdaq
  • SNPX Nasdaq
  • Market Cap
  • DGLY 3.5M
  • SNPX 3.7M
  • IPO Year
  • DGLY N/A
  • SNPX N/A
  • Fundamental
  • Price
  • DGLY $0.56
  • SNPX $2.57
  • Analyst Decision
  • DGLY
  • SNPX Strong Buy
  • Analyst Count
  • DGLY 0
  • SNPX 1
  • Target Price
  • DGLY N/A
  • SNPX $14.00
  • AVG Volume (30 Days)
  • DGLY 186.6K
  • SNPX 13.5K
  • Earning Date
  • DGLY 12-27-2024
  • SNPX 11-12-2024
  • Dividend Yield
  • DGLY N/A
  • SNPX N/A
  • EPS Growth
  • DGLY N/A
  • SNPX N/A
  • EPS
  • DGLY N/A
  • SNPX N/A
  • Revenue
  • DGLY $23,417,110.00
  • SNPX N/A
  • Revenue This Year
  • DGLY $22.14
  • SNPX N/A
  • Revenue Next Year
  • DGLY N/A
  • SNPX N/A
  • P/E Ratio
  • DGLY N/A
  • SNPX N/A
  • Revenue Growth
  • DGLY N/A
  • SNPX N/A
  • 52 Week Low
  • DGLY $0.51
  • SNPX $2.32
  • 52 Week High
  • DGLY $3.29
  • SNPX $8.78
  • Technical
  • Relative Strength Index (RSI)
  • DGLY 33.18
  • SNPX 40.67
  • Support Level
  • DGLY $0.51
  • SNPX $2.52
  • Resistance Level
  • DGLY $0.78
  • SNPX $2.80
  • Average True Range (ATR)
  • DGLY 0.10
  • SNPX 0.21
  • MACD
  • DGLY -0.01
  • SNPX -0.02
  • Stochastic Oscillator
  • DGLY 14.17
  • SNPX 7.35

About DGLY Digital Ally Inc.

Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.

About SNPX Synaptogenix Inc.

Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.

Share on Social Networks: